Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Special Feature Articles - Most Recent
    • Special Features
    • Colloquia
    • Collected Articles
    • PNAS Classics
    • List of Issues
  • Front Matter
    • Front Matter Portal
    • Journal Club
  • News
    • For the Press
    • This Week In PNAS
    • PNAS in the News
  • Podcasts
  • Authors
    • Information for Authors
    • Editorial and Journal Policies
    • Submission Procedures
    • Fees and Licenses
  • Submit
  • Submit
  • About
    • Editorial Board
    • PNAS Staff
    • FAQ
    • Accessibility Statement
    • Rights and Permissions
    • Site Map
  • Contact
  • Journal Club
  • Subscribe
    • Subscription Rates
    • Subscriptions FAQ
    • Open Access
    • Recommend PNAS to Your Librarian

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Home
Home
  • Log in
  • My Cart

Advanced Search

  • Home
  • Articles
    • Current
    • Special Feature Articles - Most Recent
    • Special Features
    • Colloquia
    • Collected Articles
    • PNAS Classics
    • List of Issues
  • Front Matter
    • Front Matter Portal
    • Journal Club
  • News
    • For the Press
    • This Week In PNAS
    • PNAS in the News
  • Podcasts
  • Authors
    • Information for Authors
    • Editorial and Journal Policies
    • Submission Procedures
    • Fees and Licenses
  • Submit
Research Article

Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates

Yizhou Dong, Kevin T. Love, J. Robert Dorkin, Sasilada Sirirungruang, Yunlong Zhang, Delai Chen, Roman L. Bogorad, Hao Yin, Yi Chen, Arturo J. Vegas, Christopher A. Alabi, Gaurav Sahay, Karsten T. Olejnik, Weiheng Wang, Avi Schroeder, Abigail K. R. Lytton-Jean, Daniel J. Siegwart, Akin Akinc, Carmen Barnes, Scott A. Barros, Mary Carioto, Kevin Fitzgerald, Julia Hettinger, Varun Kumar, Tatiana I. Novobrantseva, June Qin, William Querbes, Victor Koteliansky, Robert Langer, and Daniel G. Anderson
  1. aDavid H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139;
  2. bDepartment of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139;
  3. cDepartment of Anesthesiology, Children’s Hospital Boston, Harvard Medical School, Boston, MA 02115;
  4. dDepartment of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139;
  5. eDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139;
  6. fAlnylam Pharmaceuticals, Inc., Cambridge, MA 02142; and
  7. gInstitute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02139

See allHide authors and affiliations

PNAS first published February 10, 2014; https://doi.org/10.1073/pnas.1322937111
Yizhou Dong
aDavid H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139;
bDepartment of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139;
cDepartment of Anesthesiology, Children’s Hospital Boston, Harvard Medical School, Boston, MA 02115;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kevin T. Love
aDavid H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139;
cDepartment of Anesthesiology, Children’s Hospital Boston, Harvard Medical School, Boston, MA 02115;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Robert Dorkin
dDepartment of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sasilada Sirirungruang
eDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yunlong Zhang
aDavid H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Delai Chen
aDavid H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139;
cDepartment of Anesthesiology, Children’s Hospital Boston, Harvard Medical School, Boston, MA 02115;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roman L. Bogorad
aDavid H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hao Yin
aDavid H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yi Chen
aDavid H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arturo J. Vegas
aDavid H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139;
cDepartment of Anesthesiology, Children’s Hospital Boston, Harvard Medical School, Boston, MA 02115;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher A. Alabi
aDavid H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139;
bDepartment of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gaurav Sahay
aDavid H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karsten T. Olejnik
aDavid H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Weiheng Wang
aDavid H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139;
cDepartment of Anesthesiology, Children’s Hospital Boston, Harvard Medical School, Boston, MA 02115;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Avi Schroeder
aDavid H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139;
bDepartment of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abigail K. R. Lytton-Jean
aDavid H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel J. Siegwart
aDavid H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139;
bDepartment of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Akin Akinc
fAlnylam Pharmaceuticals, Inc., Cambridge, MA 02142; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carmen Barnes
fAlnylam Pharmaceuticals, Inc., Cambridge, MA 02142; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott A. Barros
fAlnylam Pharmaceuticals, Inc., Cambridge, MA 02142; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary Carioto
fAlnylam Pharmaceuticals, Inc., Cambridge, MA 02142; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kevin Fitzgerald
fAlnylam Pharmaceuticals, Inc., Cambridge, MA 02142; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julia Hettinger
fAlnylam Pharmaceuticals, Inc., Cambridge, MA 02142; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Varun Kumar
fAlnylam Pharmaceuticals, Inc., Cambridge, MA 02142; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tatiana I. Novobrantseva
fAlnylam Pharmaceuticals, Inc., Cambridge, MA 02142; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
June Qin
fAlnylam Pharmaceuticals, Inc., Cambridge, MA 02142; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William Querbes
fAlnylam Pharmaceuticals, Inc., Cambridge, MA 02142; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Victor Koteliansky
fAlnylam Pharmaceuticals, Inc., Cambridge, MA 02142; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Langer
aDavid H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139;
bDepartment of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel G. Anderson
aDavid H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139;
bDepartment of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139;
cDepartment of Anesthesiology, Children’s Hospital Boston, Harvard Medical School, Boston, MA 02115;
gInstitute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02139
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: dgander@mit.edu
  1. Edited* by Alexander M. Klibanov, Massachusetts Institute of Technology, Cambridge, MA, and approved January 16, 2014 (received for review December 10, 2013)

  • Article
  • Figures & SI
  • Info & Metrics
  • PDF
Loading

Significance

The safe, selective, and efficient delivery of siRNA is a key challenge to the broad application of siRNA therapeutics in humans. Motivated by the structure of lipoproteins, we developed lipopeptide nanomaterials for siRNA delivery. In vivo in mice, siRNA–lipopeptide particles provide the most potent delivery to hepatocytes (ED50 ∼ 0.002 mg/kg for FVII silencing), with the highest selectivity of delivery to hepatocytes over nontarget cell types (orders of magnitude), yet reported. These materials also show efficacy in nonhuman primates.

Abstract

siRNA therapeutics have promise for the treatment of a wide range of genetic disorders. Motivated by lipoproteins, we report lipopeptide nanoparticles as potent and selective siRNA carriers with a wide therapeutic index. Lead material cKK-E12 showed potent silencing effects in mice (ED50 ∼ 0.002 mg/kg), rats (ED50 < 0.01 mg/kg), and nonhuman primates (over 95% silencing at 0.3 mg/kg). Apolipoprotein E plays a significant role in the potency of cKK-E12 both in vitro and in vivo. cKK-E12 was highly selective toward liver parenchymal cell in vivo, with orders of magnitude lower doses needed to silence in hepatocytes compared with endothelial cells and immune cells in different organs. Toxicity studies showed that cKK-E12 was well tolerated in rats at a dose of 1 mg/kg (over 100-fold higher than the ED50). To our knowledge, this is the most efficacious and selective nonviral siRNA delivery system for gene silencing in hepatocytes reported to date.

  • lipopeptide nanomaterials
  • tissue and cell specificity
  • liver genetic disorders
  • translational research

Footnotes

  • ↵1To whom correspondence should be addressed. E-mail: dgander{at}mit.edu.
  • Author contributions: Y.D., R.L., and D.G.A. designed research; Y.D., K.T.L., J.R.D., S.S., Y.Z., D.C., R.L.B., H.Y., Y.C., A.J.V., C.A.A., G.S., K.T.O., W.W., A.S., A.K.R.L.-J., A.A., C.B., S.A.B., M.C., K.F., J.H., V. Kumar, T.I.N., J.Q., W.Q., and V. Kotelianski performed research; Y.D., K.T.L., J.R.D., S.S., Y.Z., D.C., R.L.B., H.Y., Y.C., A.J.V., C.A.A., G.S., K.T.O., W.W., A.S., A.K.R.L.-J., A.A., C.B., S.A.B., M.C., K.F., J.H., V. Kumar, T.I.N., J.Q., W.Q., V. Kotelianski, R.L., and D.G.A. analyzed data; and Y.D., K.T.L., A.J.V., C.A.A., D.J.S., R.L., and D.G.A. wrote the paper.

  • Conflict of interest statement: R.L. is a shareholder and member of the Scientific Advisory Board of Alnylam. D.G.A. is a consultant with Alnylam. R.L and D.G.A have sponsored research grants from Alnylam. Alnylam also has a license to certain intellectual property invented at Massachusetts Institute of Technology. A.A., S.A.B., M.C., K.F., J.H., V. Kumar, J.Q., and W.Q. are employed by Alnylam.

  • ↵*This Direct Submission article had a prearranged editor.

  • This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.1073/pnas.1322937111/-/DCSupplemental.

Freely available online through the PNAS open access option.

Next
Back to top
Article Alerts
Email Article

Thank you for your interest in spreading the word on PNAS.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates
(Your Name) has sent you a message from PNAS
(Your Name) thought you would like to see the PNAS web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Lipopeptides and selective siRNA delivery
Yizhou Dong, Kevin T. Love, J. Robert Dorkin, Sasilada Sirirungruang, Yunlong Zhang, Delai Chen, Roman L. Bogorad, Hao Yin, Yi Chen, Arturo J. Vegas, Christopher A. Alabi, Gaurav Sahay, Karsten T. Olejnik, Weiheng Wang, Avi Schroeder, Abigail K. R. Lytton-Jean, Daniel J. Siegwart, Akin Akinc, Carmen Barnes, Scott A. Barros, Mary Carioto, Kevin Fitzgerald, Julia Hettinger, Varun Kumar, Tatiana I. Novobrantseva, June Qin, William Querbes, Victor Koteliansky, Robert Langer, Daniel G. Anderson
Proceedings of the National Academy of Sciences Feb 2014, 201322937; DOI: 10.1073/pnas.1322937111

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Lipopeptides and selective siRNA delivery
Yizhou Dong, Kevin T. Love, J. Robert Dorkin, Sasilada Sirirungruang, Yunlong Zhang, Delai Chen, Roman L. Bogorad, Hao Yin, Yi Chen, Arturo J. Vegas, Christopher A. Alabi, Gaurav Sahay, Karsten T. Olejnik, Weiheng Wang, Avi Schroeder, Abigail K. R. Lytton-Jean, Daniel J. Siegwart, Akin Akinc, Carmen Barnes, Scott A. Barros, Mary Carioto, Kevin Fitzgerald, Julia Hettinger, Varun Kumar, Tatiana I. Novobrantseva, June Qin, William Querbes, Victor Koteliansky, Robert Langer, Daniel G. Anderson
Proceedings of the National Academy of Sciences Feb 2014, 201322937; DOI: 10.1073/pnas.1322937111
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Mendeley logo Mendeley

See related content:

  • Speeding evolution
    - Mar 06, 2014
Proceedings of the National Academy of Sciences: 118 (9)
Current Issue

Submit

Sign up for Article Alerts

Jump to section

  • Article
  • Figures & SI
  • Info & Metrics
  • PDF

You May Also be Interested in

Setting sun over a sun-baked dirt landscape
Core Concept: Popular integrated assessment climate policy models have key caveats
Better explicating the strengths and shortcomings of these models will help refine projections and improve transparency in the years ahead.
Image credit: Witsawat.S.
Model of the Amazon forest
News Feature: A sea in the Amazon
Did the Caribbean sweep into the western Amazon millions of years ago, shaping the region’s rich biodiversity?
Image credit: Tacio Cordeiro Bicudo (University of São Paulo, São Paulo, Brazil), Victor Sacek (University of São Paulo, São Paulo, Brazil), and Lucy Reading-Ikkanda (artist).
Syrian archaeological site
Journal Club: In Mesopotamia, early cities may have faltered before climate-driven collapse
Settlements 4,200 years ago may have suffered from overpopulation before drought and lower temperatures ultimately made them unsustainable.
Image credit: Andrea Ricci.
Steamboat Geyser eruption.
Eruption of Steamboat Geyser
Mara Reed and Michael Manga explore why Yellowstone's Steamboat Geyser resumed erupting in 2018.
Listen
Past PodcastsSubscribe
Birds nestling on tree branches
Parent–offspring conflict in songbird fledging
Some songbird parents might improve their own fitness by manipulating their offspring into leaving the nest early, at the cost of fledgling survival, a study finds.
Image credit: Gil Eckrich (photographer).

Similar Articles

Site Logo
Powered by HighWire
  • Submit Manuscript
  • Twitter
  • Facebook
  • RSS Feeds
  • Email Alerts

Articles

  • Current Issue
  • Special Feature Articles – Most Recent
  • List of Issues

PNAS Portals

  • Anthropology
  • Chemistry
  • Classics
  • Front Matter
  • Physics
  • Sustainability Science
  • Teaching Resources

Information

  • Authors
  • Editorial Board
  • Reviewers
  • Subscribers
  • Librarians
  • Press
  • Site Map
  • PNAS Updates
  • FAQs
  • Accessibility Statement
  • Rights & Permissions
  • About
  • Contact

Feedback    Privacy/Legal

Copyright © 2021 National Academy of Sciences. Online ISSN 1091-6490